Newsletter Subject

Banning Gain-of-Function Research Would Do Far More Harm Than Good

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Mar 16, 2024 11:22 AM

Email Preheader Text

Weekly Review Saturday, March 16, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME

[MEDPAGE TODAY]( Weekly Review Saturday, March 16, 2024 [Banning Gain-of-Function Research Would Do Far More Harm Than Good]( [FDA Approves First-Ever Drug for Serious Liver Condition]( [More States Cut Training Requirements for Some International Medical Graduates]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer]( [Largest Independent Primary Care Network in the U.S. Accused of Medicare Fraud]( [Deaths Due to Alcohol Use; Steps for the Sedentary]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Are Regulators Finally Waking Up to the Threat That Is UnitedHealth Group?]( CME SPOTLIGHT [Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches]( [Beyond Kegels: Brittany Mahomes' Pelvic Floor Woes Post-Childbirth]( [Pediatrics Taxed in This Year's Match With 249 Unfilled Positions]( [Death After Brazilian Butt Lift; Wrong-Organ Surgery Suit; Holistic Doc Investigated]( CME SPOTLIGHT [Expert Insights and System-Based Care Trends in Early-Stage NSCLC and Melanoma, Metastatic Bladder Cancer, and Relapsed/Refractory Follicular Lymphoma]( [Noninvasive Screening Tests Show Promise for Catching Colorectal Cancer]( [Another Dangerous Amoeba Linked to Neti Pots and Nasal Rinsing]( [Commonly Used Fingertip Pulse Oximeters Not Up to Snuff]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [Viagra and Alzheimer's; Migraine Consensus Statement; FDA Updates Drug Guidance]( [Can Dying Shopping Malls Fix Medical Deserts?]( [Paul Offit on the Causes and Legacy of COVID Misinformation]( CME SPOTLIGHT [Leveraging the Multidisciplinary Team to Improve Lung Cancer Care]( [Serious Issues With Slow Heartbeat Flagged for Afib Patients on Antiarrhythmics]( [Most Physicians Down on Private Equity in Healthcare]( [It's Match Week, but That Won't Fix the Physician Shortage]( CME SPOTLIGHT [PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer]( [Knowing When to Start, Knowing When to Stop]( [Online Obesity Program Helped Primary Care Patients Lose Weight]( [Published Data Show Why GSK Bailed on Its Maternal RSV Vaccine]( CME SPOTLIGHT [Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial Cancer]( [MedPod Today: AAMC Leaked Emails; 'Wild West' of Ketamine; MA Games the System]( [LSD Anxiety Win; Pimavanserin Schizophrenia Flop; 'Bright Light' for Depression?]( [Who Is at Risk of Caffeine Intoxication?]( CME SPOTLIGHT [Improving Care for Patients With NSCLC Using Evidence-Based and Guideline-Informed Biomarker Testing]( [Zero-Star Ratings: Point of Shame or Professional Pride?]( [FDA Tries to Close the Lid on Poop Transplant Company]( ['Let's Look at the Car Temperature': What We Heard This Week]( [Long COVID Patients, Advocates Rally for More Research, Funding, and Attention]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-03-16&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.